Semnur Pharmaceuticals, Inc. financial statements
Semnur Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Net income | −USD 160.42M | 10-K |
| Cash and equivalents | USD 20K | 10-Q |
Semnur Pharmaceuticals, Inc. financials on 6ix · Semnur Pharmaceuticals, Inc. on 6ix